Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review

The optimal dose of recombinant tissue plasminogen activator (rtPA) for acute ischaemic stroke (AIS) remains controversial, especially in Asian countries. We aimed to update the evidence regarding the use of low-dose versus standard-dose rtPA. We performed a systematic literature search across MEDLI...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xia, You, Shoujiang, Sato, Shoichiro, Yang, Jie, Carcel, Cheryl, Zheng, Danni, Yoshimura, Sohei, Anderson, Craig S, Sandset, Else Charlotte, Robinson, Thompson, Chalmers, John, Sharma, Vijay K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870642/
https://www.ncbi.nlm.nih.gov/pubmed/29600005
http://dx.doi.org/10.1136/svn-2017-000112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870642/
https://www.ncbi.nlm.nih.gov/pubmed/29600005
http://dx.doi.org/10.1136/svn-2017-000112

Ejemplares similares